127 related articles for article (PubMed ID: 11437932)
1. Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma.
Tamussino KF; Gücer F; Reich O; Moser F; Petru E; Scholz HS
Int J Gynecol Cancer; 2001; 11(3):236-40. PubMed ID: 11437932
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
[TBL] [Abstract][Full Text] [Related]
3. Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma.
Metindir J; Bilir Dilek G
J Cancer Res Clin Oncol; 2009 Jan; 135(1):125-9. PubMed ID: 18542999
[TBL] [Abstract][Full Text] [Related]
4. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
Heng S; Benjapibal M
Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
[TBL] [Abstract][Full Text] [Related]
5. Presence of anemia and poor prognostic factors in patients with endometrial carcinoma.
Wilairat W; Benjapibal M
Asian Pac J Cancer Prev; 2012; 13(7):3187-90. PubMed ID: 22994731
[TBL] [Abstract][Full Text] [Related]
6. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.
Scholz HS; Petru E; Gücer F; Haas J; Tamussino K; Winter R
Anticancer Res; 2000; 20(5C):3983-5. PubMed ID: 11268488
[TBL] [Abstract][Full Text] [Related]
7. The Significance of Pretreatment Thrombocytosis and Its Association With Neutrophilia in Patients With Surgically Treated Endometrial Cancer.
Takahashi R; Mabuchi S; Kuroda H; Kozasa K; Yokoi E; Matsumoto Y; Kimura T
Int J Gynecol Cancer; 2017 Sep; 27(7):1399-1407. PubMed ID: 28604454
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytosis as a prognostic factor in endometrial carcinoma.
Gücer F; Moser F; Tamussino K; Reich O; Haas J; Arikan G; Petru E; Winter R
Gynecol Oncol; 1998 Aug; 70(2):210-4. PubMed ID: 9740692
[TBL] [Abstract][Full Text] [Related]
9. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of pretreatment leukocytosis and thrombocytosis into the FIGO staging system for prognosis in surgically treated endometrial cancer.
Yokoi E; Mabuchi S; Komura N; Shimura K; Matsumoto Y; Kimura T
Int J Gynaecol Obstet; 2020 Nov; 151(2):272-278. PubMed ID: 32712993
[TBL] [Abstract][Full Text] [Related]
11. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA
Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254
[TBL] [Abstract][Full Text] [Related]
12. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
13. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma.
Ayhan A; Bozdag G; Taskiran C; Gultekin M; Yuce K; Kucukali T
Gynecol Oncol; 2006 Dec; 103(3):902-5. PubMed ID: 16828847
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population.
Gorelick C; Andikyan V; Mack M; Lee YC; Abulafia O
Int J Gynecol Cancer; 2009 Nov; 19(8):1384-9. PubMed ID: 20009894
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA
J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117
[TBL] [Abstract][Full Text] [Related]
16. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
17. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
19. Tumor anemia and thrombocytosis in patients with vulvar cancer.
Hefler L; Mayerhofer K; Leibman B; Obermair A; Reinthaller A; Kainz C; Tempfer C
Tumour Biol; 2000; 21(5):309-14. PubMed ID: 10940827
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative platelet count as index of the grading in endometrial carcinoma].
Giannella L; Menozzi G; Di Monte I; Venturini P; De Pace V; Boselli F; Ternelli G; Jasonni VM
Minerva Ginecol; 2008 Aug; 60(4):273-9. PubMed ID: 18560341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
